Prestige Consumer Healthcare executive to retire

Prestige Consumer Healthcare Inc. reports a leadership change in its operations function.

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. reports a leadership change in its operations function. On August 10, 2026, Jeffrey Zerillo informed the company of his decision to retire from his role as Senior Vice President, Operations and from all other positions he holds with the company, effective August 14, 2026.

The company’s common stock, par value $0.01 per share, continues to be listed on the New York Stock Exchange under the symbol PBH. The report is signed by Christine Sacco, Chief Financial Officer & Chief Operating Officer.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Retirement notice date: August 10, 2026 Retirement effective date: August 14, 2026 Par value per share: $0.01 per share

3 metrics

Retirement notice date August 10, 2026 Date Jeffrey Zerillo notified the company of his decision to retire

Retirement effective date August 14, 2026 Effective date of Jeffrey Zerillo’s retirement from all company positions

Par value per share $0.01 per share Par value of Prestige Consumer Healthcare common stock listed on NYSE

Key Terms

Senior Vice President, Operations, pre-commencement communications, soliciting material, common stock, par value $0.01 per share

4 terms

Senior Vice President, Operations financial

"retire from his position as Senior Vice President, Operations and from all other positions"

pre-commencement communications regulatory

"Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act"

soliciting material regulatory

"Soliciting material pursuant to Rule 14a-12 under the Exchange Act"

common stock, par value $0.01 per share financial

"Common stock, par value $0.01 per share | PBH | New York Stock Exchange"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did Prestige Consumer Healthcare (PBH) disclose?

Prestige Consumer Healthcare disclosed that Jeffrey Zerillo decided to retire as Senior Vice President, Operations and from all other company positions, effective August 14, 2026, following his notice to the company on August 10, 2026.

When is the retirement of Prestige Consumer Healthcare’s SVP Operations effective?

The retirement of Senior Vice President, Operations Jeffrey Zerillo is effective on August 14, 2026. He notified Prestige Consumer Healthcare of his decision to retire on August 10, 2026.

Which executive signed the August 2026 report for Prestige Consumer Healthcare (PBH)?

The report was signed by Christine Sacco, who serves as Chief Financial Officer & Chief Operating Officer of Prestige Consumer Healthcare Inc., on August 14, 2026.

On which exchange is Prestige Consumer Healthcare (PBH) common stock listed?

Prestige Consumer Healthcare’s common stock, par value $0.01 per share, is listed on the New York Stock Exchange under the trading symbol PBH.

What type of event does this Prestige Consumer Healthcare (PBH) 8-K describe?

The filing describes an executive officer departure under an item covering departure or appointment of directors and certain officers, specifically the retirement of the Senior Vice President, Operations of Prestige Consumer Healthcare.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:26 PM Accepted by SEC EDGAR 08/14/2026 - 04:03 PM Learn about SEC filing dates

0001295947false00012959472026-08-102026-08-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 10, 2026

PRESTIGE CONSUMER HEALTHCARE INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

001-32433

20-1297589

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

660 White Plains Road, Tarrytown, New York 10591

(Address of Principal Executive Offices) (Zip Code)

(914) 524-6800

(Registrant's telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common stock, par value $0.01 per share			PBH			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 10, 2026, Jeffrey Zerillo notified Prestige Consumer Healthcare Inc. (the “Company”) of his decision to retire from his position as Senior Vice President, Operations and from all other positions he holds with the Company, effective August 14, 2026.

                     SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 14, 2026			PRESTIGE CONSUMER HEALTHCARE INC.
			By:			/s/ Christine Sacco
						Christine Sacco
						Chief Financial Officer & Chief Operating Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB